Treatment of the disease includes both risk factor modification and efforts to improve blood flow to the lower extremity. For mild to moderate intermittent claudication, medical therapy as well as a supervised exercise program is advised. For debilitating claudication or critical limb ischemia, a ...
Antibiotics remain the cornerstone of treatment for DFIs, with the choice of therapy guided by the infection's severity and the involved pathogens. For mild to moderate infections, oral antibiotics such as amoxicillin–clavulanate, clindamycin, or doxycycline are often sufficient to address common gram...
Angiography and endovascular revascularization of pudendal artery atherosclerotic disease in patients with medically refractory erectile dysfunction. To report a technique for endovascular treatment of pudendal artery stenoses in medically refractory erectile dysfunction. Three men with known peripheral ... A ...
A family history of atherosclerotic disease Chronic renal failure Overweight or obesity Physical inactivity In peripheral artery disease, the risk factors are additive, so a person with a combination of two risk factors -- diabetes and smoking, for example -- has an increased likelihood of developin...
196,197 However, a high number of patients with N-ERD do not achieve adequate disease control with conventional approaches and thus require reoperation or short-term/continuous systemic corticosteroid administration.2,7,173,198 ATAD is a significant option for the management of CRSwNP as well as ...
Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortalityin diabetics with peripheral arterial disease: the DAVID study. Eur. Heart J. 25, 1845–1852 (2004). CAS PubMed...
The goals of treatment are to reduce mortality and morbidity, prevent heart disease or its progression, and manage comorbidities that cause and/or contribute to the pathogenesis of heart failure. Despite considerable therapeutic advances, treatment of acute decompensated heart failure has not changed muc...
Research progress of oral micro-biome in atherosclerotic cardiovascular disease. Journal of Clinical Cardiology, 2024, 40(6): 453-453. doi: 10.13201/j.issn.1001-1439.2024.06.006 [4] YANG Mengxi, XU Wenting, DAI Quan, DIAO Wei, ZHOU Peng. Imaging manifestations and research progress of ...
was approved by the FDA in 2013 for the treatment of homozygous familial hypercholesterolemia, a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease122,123. This ...
Erectile dysfunction (ED) is defined as the inability to achieve and/or maintain an erection sufficient to permit satisfactory sexual intercourse. ED may result from psychological, neurologic, hormonal, vascular, or impairment of cavernosal smooth muscle